Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7797]

EHA 2015: Does the patient with myelofibrosis feel better through pacritinib?

EHA 2015: Does the patient with myelofibrosis feel better through pacritinib?

NICE reject enzalutamide for advanced prostate cancer before chemotherapy

NICE reject enzalutamide for advanced prostate cancer before chemotherapy

Mayo clinic to study 10,000 patients for drug-gene safety

Mayo clinic to study 10,000 patients for drug-gene safety

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Oral cancer therapy combination prevents progression of advanced melanoma for over a year

Oral cancer therapy combination prevents progression of advanced melanoma for over a year

Mouse models of human colorectal cancer generated through chemokine targeting

Mouse models of human colorectal cancer generated through chemokine targeting

Challenges ahead for European clinical trials

Challenges ahead for European clinical trials

AKT inhibitors could improve radiotherapy for wide range of cancers

AKT inhibitors could improve radiotherapy for wide range of cancers

Trabectedin improves disease control in patients with advanced soft tissue sarcoma

Trabectedin improves disease control in patients with advanced soft tissue sarcoma

ASCO 2015: Lenvatinib increases progression free survival and overall response rate when used with everolimus in metastatic renal cell carcinoma

ASCO 2015: Lenvatinib increases progression free survival and overall response rate when used with everolimus in...

More from ecancer